Passage BIO, Inc.
Data quality: 83%
PASG
Nasdaq
Manufacturing
Chemicals
$11.14
▲
$1.85
(19.91%)
Mkt Cap: 35.74 M
Price
$11.14
Mkt Cap
35.74 M
Day Range
$9.26 — $11.19
52-Week Range
$5.12 — $20.00
Volume
108,083
Open $9.26
50D / 200D Avg
$8.83
26.22% above
50D / 200D Avg
$8.56
30.19% above
Quick Summary
Key Takeaways
Negative free cash flow of -31.51 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-131.23%
Below sector avg (-53.47%)
ROIC-69.97%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio2.51
Interest CoverageN/A
Valuation
PE (TTM)
-0.79
Above sector avg (-1.47)
P/B Ratio1.15
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.8 | -1.5 |
| P/B | 1.2 | 1.6 |
| ROE % | -131.2 | -53.5 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
ETFs Holding This Stock
BRSIX
BRSIX
0.03% weight
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -45.52 M |
| ROE | -131.23% | ROA | -59.37% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -31.51 M |
| ROIC | -69.97% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.51 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 33.49 M | Tangible Book Value | 31.12 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.79 | Forward P/E | N/A |
| P/B Ratio | 1.15 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -88.17% | ||
| Market Cap | 35.74 M | Enterprise Value | -17.04 M |
| Per Share | |||
| EPS (Diluted TTM) | -14.35 | Revenue / Share | N/A |
| FCF / Share | -9.82 | OCF / Share | -9.82 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 69.22% |
| SBC-Adj. FCF | -35.30 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -45.52 M | -64.77 M | -102.06 M | -136.13 M | -185.39 M |
| EPS (Diluted) | -14.35 | -1.07 | -1.86 | -2.50 | -3.48 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -49.30 M | -70.40 M | -108.39 M | -138.39 M | -185.73 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 23.28 M | 40.18 M | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | 728,000.0 | 3.08 M | 3.72 M | 3.68 M | 1.54 M |
| Interest Expense | — | — | — | — | — |
| Income Tax | 0.0 | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 62.28 M | 102.41 M | 150.55 M | 243.55 M | 355.08 M |
| Total Liabilities | 43.53 M | 41.15 M | 39.26 M | 42.18 M | 36.42 M |
| Shareholders' Equity | 18.76 M | 61.26 M | 111.28 M | 201.37 M | 318.66 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 46.30 M | 37.57 M | 21.71 M | 34.60 M | 128.97 M |
| Current Assets | 47.76 M | 78.82 M | 117.96 M | 197.04 M | 325.07 M |
| Current Liabilities | 23.08 M | 19.36 M | 16.34 M | 18.35 M | 29.50 M |
{"event":"ticker_viewed","properties":{"ticker":"PASG","listing_kind":"stock","pathname":"/stocks/pasg","exchange":"Nasdaq","country":"US"}}